Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 25057 | 23.3 |
09:34 ET | 30127 | 23.6754 |
09:36 ET | 43841 | 23.79 |
09:38 ET | 22545 | 23.76 |
09:39 ET | 26578 | 23.8599 |
09:41 ET | 44762 | 23.9 |
09:43 ET | 48266 | 23.95 |
09:45 ET | 46904 | 24 |
09:48 ET | 37861 | 24.22 |
09:50 ET | 43977 | 24.23 |
09:52 ET | 27426 | 24.1836 |
09:54 ET | 18619 | 24.105 |
09:56 ET | 29749 | 23.875 |
09:57 ET | 23332 | 23.89 |
09:59 ET | 10861 | 23.74 |
10:01 ET | 15446 | 23.81 |
10:03 ET | 6586 | 23.795 |
10:06 ET | 10470 | 23.87 |
10:08 ET | 12591 | 23.83 |
10:10 ET | 10298 | 24 |
10:12 ET | 10947 | 24 |
10:14 ET | 39703 | 23.99 |
10:15 ET | 6681 | 24.11 |
10:17 ET | 12637 | 24.1 |
10:19 ET | 25324 | 24.12 |
10:21 ET | 26750 | 24.15 |
10:24 ET | 12747 | 24.06 |
10:26 ET | 12415 | 24.04 |
10:28 ET | 10788 | 24.055 |
10:30 ET | 13340 | 24.15 |
10:32 ET | 7449 | 23.97 |
10:33 ET | 12178 | 24.18 |
10:35 ET | 44391 | 24.23 |
10:37 ET | 6834 | 24.2 |
10:39 ET | 23478 | 24.14 |
10:42 ET | 3539 | 24.18 |
10:44 ET | 15321 | 24.23 |
10:46 ET | 21287 | 24.2199 |
10:48 ET | 4555 | 24.21 |
10:50 ET | 41961 | 24.3699 |
10:51 ET | 24466 | 24.27 |
10:53 ET | 9409 | 24.25 |
10:55 ET | 7230 | 24.22 |
10:57 ET | 10242 | 24.28 |
11:00 ET | 30251 | 24.1204 |
11:02 ET | 11351 | 24.175 |
11:04 ET | 7702 | 24.26 |
11:06 ET | 8710 | 24.3 |
11:08 ET | 7709 | 24.325 |
11:09 ET | 7484 | 24.295 |
11:11 ET | 4966 | 24.28 |
11:13 ET | 15671 | 24.21 |
11:15 ET | 7679 | 24.175 |
11:18 ET | 10256 | 24.135 |
11:20 ET | 9119 | 24.16 |
11:22 ET | 11358 | 24.0201 |
11:24 ET | 5807 | 24.11 |
11:26 ET | 3553 | 24.145 |
11:27 ET | 4050 | 24.18 |
11:29 ET | 13432 | 24.27 |
11:31 ET | 7800 | 24.31 |
11:33 ET | 4162 | 24.27 |
11:36 ET | 2887 | 24.25 |
11:38 ET | 6754 | 24.29 |
11:40 ET | 8918 | 24.24 |
11:42 ET | 1628 | 24.25 |
11:44 ET | 10846 | 24.24 |
11:45 ET | 1493 | 24.225 |
11:47 ET | 11075 | 24.3 |
11:49 ET | 8234 | 24.3156 |
11:51 ET | 2131 | 24.32 |
11:54 ET | 4700 | 24.315 |
11:56 ET | 7677 | 24.355 |
11:58 ET | 11000 | 24.27 |
12:00 ET | 3404 | 24.34 |
12:02 ET | 4120 | 24.34 |
12:03 ET | 6613 | 24.33 |
12:05 ET | 6623 | 24.33 |
12:07 ET | 3049 | 24.33 |
12:09 ET | 4779 | 24.35 |
12:12 ET | 5398 | 24.355 |
12:14 ET | 7286 | 24.37 |
12:16 ET | 4809 | 24.355 |
12:18 ET | 9225 | 24.3725 |
12:20 ET | 10668 | 24.29 |
12:21 ET | 12179 | 24.23 |
12:23 ET | 6517 | 24.2 |
12:25 ET | 14976 | 24.23 |
12:27 ET | 10833 | 24.11 |
12:30 ET | 11200 | 24.125 |
12:32 ET | 4401 | 24.17 |
12:34 ET | 3851 | 24.18 |
12:36 ET | 4081 | 24.21 |
12:38 ET | 2450 | 24.15 |
12:39 ET | 2961 | 24.2 |
12:41 ET | 11417 | 24.14 |
12:43 ET | 27074 | 23.86 |
12:45 ET | 22356 | 23.87 |
12:48 ET | 11427 | 23.83 |
12:50 ET | 8885 | 23.945 |
12:52 ET | 17823 | 23.98 |
12:54 ET | 17448 | 24.0375 |
12:56 ET | 7309 | 24.0125 |
12:57 ET | 4765 | 24.005 |
12:59 ET | 15409 | 23.89 |
01:01 ET | 14579 | 23.8275 |
01:03 ET | 3028 | 23.9 |
01:06 ET | 4100 | 23.9983 |
01:08 ET | 6795 | 23.965 |
01:10 ET | 3600 | 23.93 |
01:12 ET | 2656 | 23.9 |
01:14 ET | 1700 | 23.93 |
01:15 ET | 30584 | 23.9598 |
01:17 ET | 8550 | 24 |
01:19 ET | 7564 | 23.98 |
01:21 ET | 3008 | 23.96 |
01:24 ET | 2100 | 23.97 |
01:26 ET | 10383 | 23.955 |
01:28 ET | 1945 | 24 |
01:30 ET | 1440 | 23.97 |
01:32 ET | 21876 | 23.9609 |
01:33 ET | 8654 | 23.99 |
01:35 ET | 7995 | 23.97 |
01:37 ET | 3784 | 23.95 |
01:39 ET | 5818 | 23.995 |
01:42 ET | 12002 | 23.98 |
01:44 ET | 1172 | 23.97 |
01:46 ET | 2055 | 23.98 |
01:48 ET | 7143 | 23.98 |
01:50 ET | 5684 | 23.94 |
01:51 ET | 2510 | 23.955 |
01:53 ET | 4700 | 23.976 |
01:55 ET | 2735 | 23.93 |
01:57 ET | 2765 | 23.88 |
02:00 ET | 3642 | 23.9 |
02:02 ET | 2519 | 23.88 |
02:04 ET | 3052 | 23.845 |
02:06 ET | 6192 | 23.84 |
02:08 ET | 2380 | 23.88 |
02:09 ET | 5092 | 23.93 |
02:11 ET | 1783 | 23.89 |
02:13 ET | 1110 | 23.9 |
02:15 ET | 1795 | 23.9 |
02:18 ET | 35471 | 23.81 |
02:20 ET | 4360 | 23.8105 |
02:22 ET | 5235 | 23.82 |
02:24 ET | 2508 | 23.86 |
02:26 ET | 3422 | 23.81 |
02:27 ET | 1920 | 23.8301 |
02:29 ET | 2534 | 23.89 |
02:31 ET | 1902 | 23.89 |
02:33 ET | 7322 | 23.905 |
02:36 ET | 12611 | 23.93 |
02:38 ET | 1811 | 23.96 |
02:40 ET | 9023 | 23.98 |
02:42 ET | 1200 | 23.97 |
02:44 ET | 1330 | 24 |
02:45 ET | 25334 | 24 |
02:47 ET | 7505 | 24 |
02:49 ET | 2856 | 23.96 |
02:51 ET | 5004 | 23.94 |
02:54 ET | 3001 | 23.98 |
02:56 ET | 3657 | 23.96 |
02:58 ET | 6629 | 23.97 |
03:00 ET | 7984 | 23.93 |
03:02 ET | 3180 | 23.93 |
03:03 ET | 6786 | 23.93 |
03:05 ET | 2636 | 23.875 |
03:07 ET | 2990 | 23.87 |
03:09 ET | 6528 | 23.85 |
03:12 ET | 2714 | 23.85 |
03:14 ET | 23401 | 23.88 |
03:16 ET | 12671 | 23.81 |
03:18 ET | 12323 | 23.78 |
03:20 ET | 22835 | 23.78 |
03:21 ET | 10147 | 23.81 |
03:23 ET | 9640 | 23.8 |
03:25 ET | 21195 | 23.74 |
03:27 ET | 7282 | 23.7364 |
03:30 ET | 6641 | 23.76 |
03:32 ET | 20933 | 23.81 |
03:34 ET | 10693 | 23.79 |
03:36 ET | 6231 | 23.84 |
03:38 ET | 6206 | 23.8199 |
03:39 ET | 12353 | 23.76 |
03:41 ET | 13403 | 23.76 |
03:43 ET | 13257 | 23.72 |
03:45 ET | 22324 | 23.725 |
03:48 ET | 14719 | 23.745 |
03:50 ET | 11047 | 23.73 |
03:52 ET | 12098 | 23.665 |
03:54 ET | 27260 | 23.7 |
03:56 ET | 32516 | 23.77 |
03:57 ET | 47878 | 23.73 |
03:59 ET | 462897 | 23.73 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.7B | 39.5x | --- |
ADMA Biologics Inc | 4.2B | 128.7x | --- |
Twist Bioscience Corp | 2.8B | -12.3x | --- |
Arrowhead Pharmaceuticals Inc | 2.7B | -4.6x | --- |
Axsome Therapeutics Inc | 4.5B | -14.4x | --- |
Arcellx Inc | 4.1B | -73.2x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
---|---|
Revenue (TTM) | $346.7M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.21 |
EPS | $0.60 |
Book Value | $1.06 |
P/E Ratio | 39.5x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | 38.3x |
Operating Margin | 29.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.